Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Which pain block works best after kidney surgery? new study reveals answers

NCT ID NCT06728514

Symptom relief Sponsor: Sahiwal medical college sahiwal Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compared two types of nerve blocks—erector spinae plane block and paravertebral block—for pain control after open kidney surgery. 72 adults were randomly assigned to one of the two blocks. Researchers measured pain scores, opioid use, and vital signs during the first 24 hours after surgery to see which block offered better pain relief and stability.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2/3

Runs two stages together: whether the treatment works, then large-scale confirmation.

Participants

72 people

The number who actually took part.

Started

Jan 2024

Finished

Aug 2024

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 60 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Both Genders * Age between 18 years to 60 years. * BMI ≤ 30 kg/m2 * ASA I or ASA II Exclusion Criteria: * Patients who do not give consent. * Relevant drug allergy. * Pregnancy * Alcohol or drug abuse. * Infection at the site of injection. * Taking of pain medications within 24 h before surgery. * Chronic hepatic or renal failure. * Deranged coagulation profile

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hemodynamic (MAP) stability are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hypertensive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hemodynamic (MAP) stability Hypertension Post operative analgesia Renal surgeries

Contacts and locations

Locations

  • Sahiwal Medical College,Sahiwal

    Sahiwal, Punjab Province, 57000, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.